Safety And Efficacy Study Of Orally Administered Epeleuton In Patients With NAFLD

Clinical trial NCT02941549 · COMPLETED

Trial details

NCT number: NCT02941549
Sponsor: Afimmune
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Non Alcoholic Fatty Liver Disease

Start date: 2016-12-20
Primary completion: 2019-01-02
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.